Cassava Sciences' troubled development of Alzheimer's disease candidate simufilam looks like it may have finally reached the ...
21mon MSN
The National Institutes of Health have awarded an epidemiology professor at the University of Pennsylvania $11 million to ...
A future treatment for Alzheimer disease may involve a nasal spray. Researchers at Università Cattolica and Fondazione Policlinico Universitario A. Gemelli IRCCS have discovered that by inhibiting the ...
According to a TSA spokesperson, the Transportation Security Administration (TSA) predicts a 6% increase in holiday travel ...
The active agent in the nasal spray, 2-bromopalmitate, carries a high risk of interfering with a number of processes, making ...
Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate ...
Rep. Maxine Waters (D-CA) recently introduced the Alzheimer’s Caregiver Support Act (HR 10192). The bill, which would ...
To determine the diagnostic accuracy of the results of CSF tests compared to the gold standard PET imaging, the Munich researchers evaluated the data of over 400 patients with suspected Alzheimer's ...
Alector Therapeutics, working with AbbVie, was testing whether modulating immune cells in brain would slow Alzheimer's ...
TAMPA — November marks National Alzheimer’s Disease Awareness Month. According to the Alzheimer’s Association, nearly 7 ...
Alector reported a Phase 2 failure for an AbbVie-partnered Alzheimer’s program Monday afternoon and said it will ...
While everyone gears up for one of the busiest travel times of the year, the Alzheimer’s Foundation of America is offering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback